Discover

ANGO
AngioDynamics, Inc.
11.52
2 x 8.54
1 x 11.56
bid
ask
+
0.29
2.58%
2 @ 05:03 PM
11.36 -0.16 (1.39%)
Ytd-10.28%
1y3.41%
10.87
day range
11.97
9.70
52 week range
16.13
Open11.06Prev Close11.23Low10.87High11.97Mkt Cap484.47M
Vol2.16MAvg Vol557.83KEPS-0.88P/EN/AForward P/E-36.21
Beta0.67Short Ratio2.88Inst. Own81.31%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning01-0650-d Avg15.38200-d Avg12.491yr Est13.00

ANGO News

ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y
zacks.com
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y

AngioDynamics beats first-quarter earnings estimates as revenues rise 6.9% on strong Med Tech growth

AngioDynamics Stock Is Falling Thursday: What's Going On?
benzinga.com
AngioDynamics Stock Is Falling Thursday: What's Going On?

AngioDynamics Inc. (NASDAQ:ANGO) stock plunged more than 21% Thursday despite reporting better-than-

AngioDynamics Stock Is Falling Thursday: What's Going On?
benzinga.com
AngioDynamics Stock Is Falling Thursday: What's Going On?

ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffir

Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
benzinga.com
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings

U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo be

AngioDynamics, Inc. (ANGO) Q1 2027 Earnings Call Transcript
seekingalpha.com
AngioDynamics, Inc. (ANGO) Q1 2027 Earnings Call Transcript

AngioDynamics, Inc. (ANGO) Q1 2027 Earnings Call Transcript

Why AngioDynamics Crashed Today
fool.com
Why AngioDynamics Crashed Today

AngioDynamics beat on both top and bottom lines this morning. The company still lost $0.04 per share

AngioDynamics Q1 Earnings Call Highlights
marketbeat.com
AngioDynamics Q1 Earnings Call Highlights

AngioDynamics NASDAQ: ANGO reported fiscal 2027 first-quarter revenue growth of 6.9% to $80.9 millio

AngioDynamics Q1 2027 Earnings Call: Complete Transcript
benzinga.com
AngioDynamics Q1 2027 Earnings Call: Complete Transcript

AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript fro

AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
zacks.com
AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates

AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Es

AngioDynamics (NASDAQ:ANGO) Announces FY 2027 Earnings Guidance
defenseworld.net
AngioDynamics (NASDAQ:ANGO) Announces FY 2027 Earnings Guidance

AngioDynamics (NASDAQ: ANGO - Get Free Report) updated its FY 2027 earnings guidance on Thursday. Th

Earnings Scheduled For October 8, 2026
benzinga.com
Earnings Scheduled For October 8, 2026

Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss

benzinga.com
AngioDynamics Appoints Eric Honroth As President And CEO, Effective November 2

Mr. Honroth will succeed Jim Clemmer, who will depart the Board on November 2, 2026, and will remain

benzinga.com
AngioDynamics Affirms FY2027 Adj EPS Guidance of $(0.29)-$(0.24) vs $(0.27) Est; Affirms FY2027 Sale

AngioDynamics (NASDAQ:ANGO) affirms FY2027 Adj EPS guidance from $(0.29)-$(0.24) to $(0.29)-$(0.24)

benzinga.com
AngioDynamics Q1 Adj. EPS $(0.04) Beats $(0.11) Estimate, Sales $80.915M Beat $80.500M Estimate

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.04) per share which beat the analyst co

AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability
businesswire.com
AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives M

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer
businesswire.com
AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
businesswire.com
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipien

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026
businesswire.com
AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focu

32,900 Shares in AngioDynamics, Inc. $ANGO Acquired by Canada Pension Plan Investment Board
defenseworld.net
32,900 Shares in AngioDynamics, Inc. $ANGO Acquired by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board purchased a new position in shares of AngioDynamics, Inc. (NASD

AngioDynamics, Inc. $ANGO Shares Purchased by Bank of America Corp DE
defenseworld.net
AngioDynamics, Inc. $ANGO Shares Purchased by Bank of America Corp DE

Bank of America Corp DE grew its holdings in shares of AngioDynamics, Inc. (NASDAQ: ANGO) by 262.7%

AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
zacks.com
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?

AngioDynamics (ANGO) reported earnings 30 days ago. What's next for the stock?

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market

AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027
marketbeat.com
AngioDynamics Sees MedTech Becoming Majority of Revenue in Fiscal 2027

AngioDynamics NASDAQ: ANGO expects its MedTech business to become the majority of company revenue in

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?
zacks.com
Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising c

ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
zacks.com
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus

AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs

ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
zacks.com
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?

AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative

AngioDynamics to Participate in Upcoming Investor Conferences
gurufocus.com
AngioDynamics to Participate in Upcoming Investor Conferences

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused

AngioDynamics to Participate in Upcoming Investor Conferences
businesswire.com
AngioDynamics to Participate in Upcoming Investor Conferences

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medi

benzinga.com
HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $19

HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and rais

benzinga.com
Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $20

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and raises

Full Transcript: AngioDynamics Q4 2026 Earnings Call
benzinga.com
Full Transcript: AngioDynamics Q4 2026 Earnings Call

AngioDynamics (NASDAQ:ANGO) released fourth-quarter financial results and hosted an earnings call on

Earnings Scheduled For July 14, 2026
benzinga.com
Earnings Scheduled For July 14, 2026

Companies Reporting Before The Bell • Grupo Aeroportuario del (NYSE:PAC) is likely to report quarter

benzinga.com
AngioDynamics Sees FY2027 Adj EPS $(0.29)-$(0.24) vs $(0.16) Est; Sees Sales $336.000M-$341.000M vs

AngioDynamics (NASDAQ:ANGO) is looking for FY2027 Adj EPS of $(0.29)-$(0.24) vs $(0.16) analyst esti

benzinga.com
AngioDynamics Q4 Adj. EPS $(0.07) Beats $(0.09) Estimate, Sales $86.607M Beat $80.400M Estimate

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

benzinga.com
AngioDynamics Says FDA Approves IDE Application To Initiate RELIEF Study Evaluating NanoKnife IRE Pl

AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring healthy blood f

Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stocks Moving Higher in Wednesday's Pre-Market Session
benzinga.com
Marvell Technology Soars on NVIDIA CEO's Endorsement, Joins Relmada Therapeutics and Other Big Stock

U.S. stock futures surged on Wed. as Nasdaq futures rose over 7%, driven by AI. Marvell's stock

benzinga.com
AngioDynamics Announces 2-Yr Results From PRESERVE Pivotal Trial Demonstrating Durable Oncologic Con

Pivotal U.S. Data Show Sustained Oncologic Control and Safety Profile at 24 monthsResults Presented

benzinga.com
Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $16

Canaccord Genuity analyst John Young maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers

Earnings Scheduled For April 2, 2026
benzinga.com
Earnings Scheduled For April 2, 2026

benzinga.com
AngioDynamics Raises FY2026 Adj EPS Guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) vs $(0.29) Est;

AngioDynamics (NASDAQ:ANGO) raises FY2026 Adj EPS guidance from $(0.33)-$(0.23) to $(0.30)-$(0.23) v

benzinga.com
AngioDynamics Q3 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $78.423M Beat $76.767M Estimate

AngioDynamics (NASDAQ:ANGO) reported quarterly losses of $(0.07) per share which beat the analyst co

Nasdaq Gains Over 1% On War De-Escalation Hopes: Investor Fear Eases, But Fear & Greed Index Remains In 'Extreme Fear' Zone
benzinga.com
Nasdaq Gains Over 1% On War De-Escalation Hopes: Investor Fear Eases, But Fear & Greed Index Remains

Stocks end higher, Fear & Greed Index eases, Trump suggests quick military withdrawal from Iran,

Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday
benzinga.com
Acuity, Lindsay And 3 Stocks To Watch Heading Into Thursday

U.S. stock futures trading lower, Acuity and Visionary Holdings report strong earnings, Lindsay Cor

Dow Jumps Over 400 Points; US Services Activity Falls In December
benzinga.com
Dow Jumps Over 400 Points; US Services Activity Falls In December

US Stocks Mixed; Nasdaq Gains Over 50 Points
benzinga.com
US Stocks Mixed; Nasdaq Gains Over 50 Points

Stock Market Today: Dow Futures Slip, S&P 500 Rises Amid Mixed Trade—Berkshire, Occidental, Fermi In Focus
benzinga.com
Stock Market Today: Dow Futures Slip, S&P 500 Rises Amid Mixed Trade—Berkshire, Occidental, Fermi In

U.S. stock futures were fluctuating on Thursday following Wednesday's record advances. Futures o

benzinga.com
Earnings Scheduled For July 15, 2025

benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gold Moves Higher; US Private Sector Job Growth Tops Estimates
benzinga.com
Gold Moves Higher; US Private Sector Job Growth Tops Estimates

Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
benzinga.com
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Mo